BIAL Becomes Founding Member of Orphan Therapeutics Accelerator
BIAL, Portugal’s century-old biopharmaceutical champion, has become a founding member of the Orphan Therapeutics Accelerator (OTXL), a nonprofit biotech initiative launched in June 2024 to revive and advance treatments for ultra rare diseases.In a statement released in April 2025, BIAL confirmed its commitment to help identify, develop, and commercialize two to three discontinued therapeutic programs […]